M
0.215
-0.01 (-2.27%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (MY) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | METRO | - | - |
AIStockmoo Score
1.2
| Analyst Consensus | 0.0 |
| Insider Activity | 3.5 |
| Price Volatility | 3.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.0 |
| Average | 1.20 |
|
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DR TAY SWI PENG @ TEE SWI PENG | 0.215 | - | 540,000 | 116,600 |
| Aggregate Net Quantity | 540,000 | |||
| Aggregate Net Value ($) | 116,600 | |||
| Aggregate Avg. Buy ($) | 0.215 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DR TAY SWI PENG @ TEE SWI PENG | Director | 19 Dec 2024 | Acquired (+) | 160,000 | 0.220 | 35,200 |
| DR TAY SWI PENG @ TEE SWI PENG | Substantial Shareholder | 19 Dec 2024 | Acquired (+) | 160,000 | 0.220 | 35,200 |
| DR TAY SWI PENG @ TEE SWI PENG | Director | 17 Dec 2024 | Acquired (+) | 110,000 | 0.210 | 23,100 |
| DR TAY SWI PENG @ TEE SWI PENG | Substantial Shareholder | 17 Dec 2024 | Acquired (+) | 110,000 | 0.210 | 23,100 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |